The mission of the company is to acquire and build a balanced portfolio of life sciences assets without typical clinical regulatory timelines. Currently Tauriga has two principal businesses: a consumer natural wellness business that includes medicinal (not recreational) cannabis products and non-cannabis-containing dietary supplements, and a synthetic biology platform for industrial cleantech, namely a “wastewater to value” technology. The two businesses provide good balance by sector and by customer type, yet both rely on innovative science, and both have an overall “green” theme. Tauriga’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses.
TAUG Detailed Quote
|Day's Range:||0.0013 - 0.0017|
|52wk Range:||0.0013 - 0.0120|
TAUG Recent Headlines
- Tauriga Sciences Inc. Confirms Court Date on May 23, 2017 Concerning the Motions to Set Matter For Trial and Trial By Jury 04/28/2017 02:15 PM[Marketwired] - Tauriga Sciences Inc. , a Company engaged in the building of businesses in the life sciences space, has today announced that a court date had been set for 1:30pm EST Tuesday, May 23, 2017 in the Federal ...
- Tauriga Sciences Inc. Secures More than $100,000 USD of Additional Funding from Existing Institutional & Accredited Individual Investors 03/28/2017 03:56 PM[Marketwired] - Tauriga Sciences Inc. , a Company engaged in building businesses in the life sciences space, has today announced that it has secured additional financing in excess of $100,000 USD from two existing institutional ...
- Tauriga Sciences, Inc. Notified by Federal District Court New Jersey of April 17, 2017 Trial Status Conference 03/07/2017 12:30 PM[Marketwired] - Tauriga Sciences, Inc. , a company engaged in building businesses in the life sciences space, has today provided its shareholders with an update on the status of its ongoing federal lawsuit against its ...
- TAURIGA SCIENCES, INC. Financials 02/03/2017 06:04 PM
- TAURIGA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report 01/31/2017 03:51 PM